Skip to main content

Political Pills: Psychopharmaceuticals and Neoliberalism as Mutually Supporting

  • Chapter
  • First Online:

Abstract

This chapter argues that a core explanatory variable in the spread of psychopharmaceuticals has been the ability of such products since the 1980s to serve key aims of the neoliberal political economy. Thus to understand the expansion of psychopharmaceutical consumption since the 1980s, we must go beyond the machinations of the pharmaceutical industry and psychiatric profession, to inspect the deeper neoliberal interests, aims and logics to which both profession and industry have been responsive and beholden. Psychopharmaceuticals, in other words, have enjoyed rapid ascent by being configured as consistent with key neoliberal aims of increasing ‘labour productivity’ and of furthering ‘commodification’ while themselves benefitting from ‘deregulation’. While reform of psychiatric and pharmaceutical practices certainly is long overdue, unless political will grows sufficiently to tackle systemic corruptions and excesses in the research, regulation and distribution of psychopharmaceuticals, little may transpire in the form of tangible change.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Abraham, J. (2005). Regulating the drugs industry transparently: The UK government has not gone far enough in responding to a critical inquiry. British Medical Association, 331(7516), 528–529.

    Google Scholar 

  • Abraham, J. (2008). Sociology of pharmaceuticals development and regulation: A realist empirical research programme. Sociology of Health and Illness, 30(6), 869–885.

    Article  PubMed  Google Scholar 

  • Abraham, J. (2009). The pharmaceutical industry, the state and the NHS. In J. Gabe & M. Calnan (Eds.), The new sociology of the health service. London: Routledge.

    Google Scholar 

  • Adair, R. F., & Holmgren, L. R. (2005). Do drug samples influence resident prescribing behavior? A randomized trail. The American Journal of Medicine, 118(8), 881–884.

    Article  PubMed  Google Scholar 

  • Anderson, B. (2015, November 5). Neoliberal affects. Progress in Human Geography. doi:10.1177/0309132515613167.

  • Anderson, S., & Cavanagh, J. (2000). Top 200: The rise of corporate global power. Washington, DC: Institute for Policy Studies.

    Google Scholar 

  • Andrain, C. F., & Smith, J. T. (2004). Political democracy, trust and social justice: A comparative overview. Boston: Northeastern University Press.

    Google Scholar 

  • Angell, M. (2011). The illusions of psychiatry. The New York Review of Books, 58(12), 82–84.

    Google Scholar 

  • Arthur, M. (2006). Struggle and the prospects for world government. Bloomington, IN: Trafford Publishing.

    Google Scholar 

  • Attridge, M., Amaral, T., Bjornson, T., Goplerud, E., Herlihy, P., McPherson, T., et al. (2009). History and growth of the EAP field. EASNA Research Notes, 1(1), 1–4.

    Google Scholar 

  • Bardhan, P., & Roemer, J. E. (1992). Market socialism, a case for rejuvenation. Journal of Economic Perspectives, 6(3), 101–116.

    Article  Google Scholar 

  • BCC Research Report. (2011). Drugs for treating mental disorders: Technologies and global markets. Retrieved from http://www.bccresearch.com/market-research/pharmaceuticals/mental-disorders-drugs-phm074a.html

  • Béhague, D. P. (2009). Psychiatry and Politics in Pelotas, Brazil: The equivocal quality of conduct disorder and related diagnoses. Medical Anthropology Quarterly, 23(4), 455–482.

    Article  PubMed  PubMed Central  Google Scholar 

  • Berdayes, V., & Murphy, J. W. (Eds.). (2015). Neoliberalism, economic radicalism, and the normalization of violence. New York, NY: Springer.

    Google Scholar 

  • Berlin, I. (1969). Four essays on liberty. Oxford: Oxford University Press.

    Google Scholar 

  • Bermejo, R. (2014). Handbook for a sustainable economy. New York, NY: Springer.

    Book  Google Scholar 

  • Bourdieu, P. (2002). The weight of the world: Social suffering in contemporary society. Palo Alto: Stanford University Press.

    Google Scholar 

  • Bracken, P., et al. (2012). Psychiatry beyond the current paradigm. British Journal of Psychiatry, 201, 430–434.

    Article  PubMed  Google Scholar 

  • Brauser, D. (2013). Psychiatrists top the list of big pharma payments again. Retrieved from http://www.medscape.com/viewarticle/780835

  • Brezis, E., & Cariolle, J. (2015). Measuring conflicts of interest: A revolving door indicator. Working Papers No. P122. Retrieved from http://EconPapers.repec.org/RePEc:fdi:wpaper:2029

  • Campbell, E. G., Weissman, J. S., Ehringhaus, S., Sowmya, R., Rao, R., Moy, B., et al. (2007). Institutional Academic-Industry relationships. The Journal of the American Medical Association, 298(15), 1779–1786.

    Article  PubMed  Google Scholar 

  • Caplan, P. (1995). They say you’re crazy. New York: DaCapo Press.

    Google Scholar 

  • Carlat, D. (2010). Unhinged: The trouble with psychiatry—A doctor’s revelations about a profession in crisis. New York: First Free Press.

    Google Scholar 

  • Carter, J. (1979). Crisis of confidence. Retrieved from http://www.cartercenter.org/news/editorials_speeches/crisis_of_confidence.html

  • Chan, A. W., & Altman, D. G. (2005). Identifying outcome reporting bias in randomized trials on PubMed: Review of publications and survey of authors. British Medical Journal, 330, 753–759.

    Article  PubMed  PubMed Central  Google Scholar 

  • Choudhry, N. K., Stelfox, H. T., & Detsky, A. S. (2002). Relationships between authors of clinical practice guidelines and the pharmaceutical industry. The Journal of the American Medical Association, 287(5), 612–617.

    Article  PubMed  Google Scholar 

  • Coppen, A. (1967). The biochemistry of affective disorders. The British Journal of Psychiatry, 113, 1237–1264.

    Article  PubMed  Google Scholar 

  • Cooper, R. (2004). What is wrong with the DSM? History of Psychiatry, 15(1), 5–25.

    Article  Google Scholar 

  • Cosgrove, L., Krimsky, S., Vijayaraghavan, M., & Schneider, L. (2006). Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychotherapy and Psychosomatics, 75, 154–160.

    Article  PubMed  Google Scholar 

  • Crott, R. G., & Gilis, P. (1998). Economic comparisons of the pharmacotherapy of depression: An overview. ACTA Psychiatrica Scandinavia, 97, 241–252.

    Article  Google Scholar 

  • Curtis, A. (2007). The Trap. Dir. Adam Curtis. BBC 2 Production.

    Google Scholar 

  • Das, V., Kleinman, A., Lock, M., Ramphele, M., & Reynolds, P. (Eds.). (2001). Remaking a world: Violence, social suffering and recovery. Oakland: University of California Press.

    Google Scholar 

  • Davies, J. (2011). The importance of suffering: The value and meaning of emotional discontent. London: Routledge.

    Google Scholar 

  • Davies, J. (2013). Cracked: Why psychiatry is doing more harm than good. London: Icon Books.

    Google Scholar 

  • Davies, W. (2015). The happiness industry: How the government and big business sold us well-being. London: Verso Books.

    Google Scholar 

  • Davies, J. (2016). The construction of DSM-III: A process of voting and committee consensus. Anthropology and Medicine, 23(3): 1–15.

    Google Scholar 

  • De Vos, J. (2012). Psychologisation in times of globalisation (concepts for critical psychology). London: Routledge.

    Google Scholar 

  • Diagnostic and Statistical Manual of Mental Disorders (3rd ed.). (1980). Washington: American Psychiatric Association.

    Google Scholar 

  • Dillon, S. (2012). Possessed by death: The neoliberal-carceral state, Black feminism, and the afterlife of slavery. Radical History Review, 112, 113–125.

    Article  Google Scholar 

  • Dow, J. (1986). Universal aspects of symbolic healing: A theoretical synthesis. American Anthropologist, 88(1), 56–69.

    Article  Google Scholar 

  • Ecks, S. (2005). Pharmaceutical citizenship: Antidepressant marketing and the promise of demarginalization of India. Anthropology and Medicine, 12(3), 239–254.

    Article  PubMed  Google Scholar 

  • EFPIA. (2016). The EFPIA code on disclosure and transfers of value from pharmaceutical companies to healthcare professionals and healthcare organisations. Retrieved from http://transparency.efpia.eu/the-efpia-code-2

  • Espostio, L., & Perez, F. M. (2014). Neoliberalism and the commodification of mental health. Humanity & Society, 38(4), 414–442.

    Article  Google Scholar 

  • Fischer, R. (2006). The expansion of intellectual property rights by international agreement: A case study comparing Chile and Australia’s bilateral FTA negotiations with the U.S. Loyola of Los Angeles International & Comparative Law Review, 28, p. 129.

    Google Scholar 

  • Foucault, M. (2004). The birth of biopolitics: Lectures at the College de France 1978–1979. London: Palgrave Macmillan.

    Google Scholar 

  • Frances, A. (2013). Saving normal: An insider’s revolt against out-of-control psychiatric diagnosis, DSM-5, big pharma, and the medicalization of ordinary life. New York, NY: William Morrow.

    Google Scholar 

  • Friedli, L., & Stearn, R. (2015). Positive affect as coercive strategy: Conditionality, activation and the role of psychology in UK government workfare programmes. Medical Humanities, 41(1), 40–47.

    Article  PubMed  PubMed Central  Google Scholar 

  • Friedman, M. (1962). Capitalism and freedom. Chicago: University of Chicago Press.

    Google Scholar 

  • Friedman, M. (2008). Free to choose: A personal statement. New York, NY: Harvest.

    Google Scholar 

  • Gaines, A. D. (1992). From DSM-I to III-R; Voices of self, mastery and the other: A cultural constructivist reading of U.S. psychiatric classification. Social Science and Medicine, 35(1), 3–24.

    Article  PubMed  Google Scholar 

  • Gotzsche, P. (2013). Deadly medicines and organised crime: How big pharma has corrupted healthcare. London: Radcliff Publishing.

    Google Scholar 

  • Greenberg, P. E., Stiglin, L. E., Finkelstein, S. N., & Berndt, E. R. (1993). The economic burdens of depression in 1990. Journal of Clinical Psychiatry, 54, 405–418.

    PubMed  Google Scholar 

  • Greenslit, N., & Kaptchuk, T. (2012). Antidepressants and advertising: Psychopharmaceuticals in crisis. Yale Journal of Biology and Medicine, 85(1), 153–158.

    PubMed  PubMed Central  Google Scholar 

  • Hall, S., & O’Shea, A. (2013). Common-sense neoliberalism. Soundings, 55, 8–24.

    Article  Google Scholar 

  • Harvey, D. (2007). A brief history of neoliberalism. New York, NY: Oxford University Press.

    Google Scholar 

  • Health and Social Care Information Centre. (2012) Prescribing by GP practice, October to December 2012. Retrieved from http://www.qualitywatch.org.uk/indicator/rates-antidepressant-prescribing-across-england

  • Healy, D. (2006a). Let them eat Prozac: The unhealthy relationship between the pharmaceutical industry and depression. New York, NY: NYU Press.

    Google Scholar 

  • Healy, D. (2006b). Did regulators fail over selective serotonin reuptake inhibitors? British Medical Journal, 333(7558), 92–95.

    Article  PubMed  PubMed Central  Google Scholar 

  • Healy, D. (2013). Pharmageddon. California: University of California Press.

    Google Scholar 

  • Hedgehog Review. (2003). The commodification of everything. The Hedgehog Review, 5(2), 5–6.

    Google Scholar 

  • Heinz, J. P., Paik, A., & Southworth, A. (2003). Lawyers for conservative causes: Clients, ideology, and social distance. Law and Society Review, 37, 5–50.

    Article  Google Scholar 

  • Helman, C. (1997). Culture, health and illness. London: B H.

    Google Scholar 

  • Hickel, J. (2012). A short history of neoliberalism (and how we can fix it). New Left Project. Retrieved from http://www.newleftproject.org/index.php/site/article_comments/a_short_history_of_neoliberalism_and_how_we_can_fix_it

  • House of Commons Health Committee. (2005). The influence of the pharmaceutical industry. London: The Stationery Office Limited.

    Google Scholar 

  • House, R., & Loewenthal, D. (2008). Against and for CBT: Towards a constructive dialogue? London: PCCS Books.

    Google Scholar 

  • James, O. (2008). The selfish capitalist: Origins of affluenza. London: Vermillion.

    Google Scholar 

  • Jones, R., Pykett, J., & Whitehead, M. (2013). Psychological governance and behaviour change. Policy Politics, 41(2), 159–182.

    Article  Google Scholar 

  • Kinderman, P. (2014). A prescription for psychiatry: Why we need a whole new approach to mental health and wellbeing. London: Palgrave Macmillan.

    Book  Google Scholar 

  • Kirmayer, L. J., & Minas, H. (2000). The future of cultural psychiatry: An international perspective. Canadian Journal of Psychiatry, 45(5), 438–446.

    Article  PubMed  Google Scholar 

  • Klein, N. (2014). This changes everything: Capitalism vs. the climate. London: Penguin.

    Google Scholar 

  • Kleinman, A. (1991 [1988]). Rethinking psychiatry. New York: Free Press.

    Google Scholar 

  • Kleinman, A. (1997). Social suffering. Oakland: University of California Press.

    Google Scholar 

  • Kleinman, A. (2012). Rebalancing Academic Psychiatry: Why it needs to happen—And soon. The British Journal of Psychiatry, 201, 421–422.

    Article  PubMed  Google Scholar 

  • Kotz, D, M. (2015). The rise and fall of neoliberal capitalism. Massachusetts: Harvard University Press.

    Google Scholar 

  • Krause, R. (2005). Depression, antidepressants and an examination of epidemological changes. The Journal of Radical Psychology, 4(1). Retrieved from: http://www.radicalpsychology.org/vol4- 1/krause.html

  • Kutchins, H., & Kirk, S. A. (1986). The reliability of DSM-III: A critical review. Social Work Research and Abstracts, 22, 3–12.

    Article  Google Scholar 

  • Lakoff, A. (2004). The Anxieties of Globalization: Antidepressant sales and economic crisis in Argentina. Social Studies of Science, 34, 247–269.

    Article  PubMed  Google Scholar 

  • Larner, W. (2003). Neoliberalism? Environment and Planning D: Society and Space, 29, 509–512.

    Article  Google Scholar 

  • Lawrence, A. J., Jones, S., Cohen, J., & Zeanah, C. H. (Eds.). (2000). The impact of poverty on the mental health and development of very young children, Handbook of infant mental health (2nd ed.). New York, NY: Guilford Press.

    Google Scholar 

  • Layard, R. (2006). The depression report: A new deal for depression and anxiety disorders. The Centre for Economic Performance’s Mental Health. Retrieved from http://cep.lse.ac.uk/pubs/download/special/depressionreport.pdf

  • Leo, J., & Lacasse, J. R. (2008). The media and the chemical imbalance theory of depression. Society, 45, 35–45.

    Article  Google Scholar 

  • Lewis, S. (2010). Neoliberalism, conflict of interest, and the governance of health research in Canada. Open Medicine, 4(1), 1–4.

    Article  Google Scholar 

  • Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003). Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. British Medical Journal, 326, 1167–1170.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lieberman, J. A. (2015). Shrinks: The untold story of psychiatry. New York, NY: Little Brown and Company.

    Google Scholar 

  • Littlewood, R. (2001). Pathologies of the West: The anthropology of mental illness in Europe and America. Ithica: Cornell University Press.

    Google Scholar 

  • Lo, B., & Field, M. J. (2009). Conflict of interest in medical research, education, and practice. Institute of Medicine (US) Committee on Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: National Academies Press.

    Google Scholar 

  • Luhrmann, T. (2000). Of two minds: The growing disorder in American psychiatry. New York, NY: Alfred A. Knopf.

    Google Scholar 

  • Macdonald, S., Morrison, J., Maxwell, M., Munoz-Arroyo, R., Power, A., Smith, M., et al. (2009). A coal face option: GPs’ perspectives on the rise in antidepressant prescribing. British Journal of General Practice, 59(566), 299–307.

    Article  Google Scholar 

  • Mai, M. (2005). Psychiatric comorbidity: An artefact of current diagnostic systems? The British Journal of Psychiatry, 186, 182–184.

    Article  Google Scholar 

  • Marmor, J. (1962). Psychoanalytic therapy as an educational process: Common denominations in therapeutic approaches of different therapeutic “schools”. In J. H. Masserman (Ed.), Psycho-analytic education. London: Grune and Stratton.

    Google Scholar 

  • Martin, E. (2006). Pharmaceutical virtue. Culture, Medicine and Psychiatry, 30(2), 157–174.

    Article  PubMed  Google Scholar 

  • Martinez, E., & García, A. (2000). What is “neo-liberalism?” A brief definition. New York: The New Press.

    Google Scholar 

  • Marx, K., & Engels, F. (1975) Collected works. (Vol. 5). London: Lawrence and Wishart.

    Google Scholar 

  • McGuigan, J. (2014). The neoliberal self. Culture Unbound, 6, 223–240.

    Article  Google Scholar 

  • Mills, C. W. (1959). The sociological imagination. Oxford: University of Oxford Press.

    Google Scholar 

  • Mirowski, P. (2013). Never let a serious crisis go to waste: How neoliberalism survived the financial meltdown. London: Verso Books.

    Google Scholar 

  • Moncrieff, J. (2013). The bitterest pills: The troubling story of antipsychotic drugs. London: Palgrave Macmillan.

    Book  Google Scholar 

  • Murali, V., & Oyebode, F. (2004). Poverty, social inequality and mental health. Advances in Psychiatric Treatment, 10(3), 216–224.

    Article  Google Scholar 

  • Nast, H. (2006). Loving … whatever: Alienation, neoliberalism and pet-love in the twenty-first century. Acme, 5(2), 3–8.

    Google Scholar 

  • OECD. (2009). Revolving doors, accountability and transparency—Emerging regulatory concerns and policy solutions in the financial crisis. Public Governance Committee, Paris.

    Google Scholar 

  • OECD. (2015). The future of productivity. Retrieved from http://www.oecd.org/eco/growth/OECD-2015-The-future-of-productivity-book.pdf

  • Ong, A. (2007). Neoliberalism as mobile technology. Transactions of the Institute of British Geographers, 32, 3–8.

    Article  Google Scholar 

  • Orlowski, J. P., & Wateska, L. (1992). The effects of pharmaceutical firm enticements on physician prescribing patterns. Chest, 102, 270–273.

    Article  PubMed  Google Scholar 

  • Paris, J. (2013). Fads & fallacies in psychiatry. London: RCPSYCH.

    Google Scholar 

  • Piketty, T. (2014). Capitalism in the twenty-first century. Massachusetts: Harvard University Press.

    Book  Google Scholar 

  • Pilgrim, D., & Rogers, A. (2014). A sociology of mental health and illness. Berkshire: Open University Press.

    Google Scholar 

  • Prince, M., Patel, V., Saxena, S., Maj, M., Maselko, J., Phillips, M. R., et al. (2007). No health without mental health. The Lancet, 370(9590), 859–877.

    Article  Google Scholar 

  • Reeves, A., McKee, M., & Stuckler, D. (2014). Economic suicides in the great recession in Europe and North America. The British Journal of Psychiatry, 205(3), 246–247.

    Article  PubMed  Google Scholar 

  • Rizq, R. (2014). Perversion, neoliberalism and therapy: The audit culture in mental health services. Psychoanalysis, Culture & Society, 19, 209–218. doi:10.1057/pcs.2014.15.

    Article  Google Scholar 

  • Roberts, R. (2015). Psychology and capitalism: The manipulation of mind. London: Zero Books.

    Google Scholar 

  • Rose, H. (2003). The commodification of virtual reality: The Icelandic health sector database. In A. H. Goodman, D. Heath, & S. M. Lindee (Eds.), Anthropology and Science beyond the Two-Culture Divide. Oakland: University of California Press.

    Google Scholar 

  • Ross, J. S., et al. (2007). Pharmaceutical company payments to physicians early experiences with disclosure laws in Vermont and Minnesota. The Journal of the American Medical Association, 297(11), 1216–1223.

    Article  PubMed  Google Scholar 

  • Ross, J. S., Hill, K. P., Egilman, D. S., & Krumholz, H. M. (2008). Guest authorship and ghost-writing in publications related to rofecoxib: A case study of industry documents from rofecoxib litigation. Journal of the American Medical Association, 299(15), 1800–1812.

    Article  PubMed  Google Scholar 

  • Saxena, S., Thornicroft, G., Knapp, M., & Whiteford, H. (2007). Resources for mental health: Scarcity, inequity, and inefficiency. The Lancet, 370(9590), 878–889.

    Article  Google Scholar 

  • Scharff, C. (2011). Disarticulating feminism: Individualization, neoliberalism and the othering of Muslim women. European Journal of Women’s Studies, 18(2), 119–134.

    Article  Google Scholar 

  • Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorders: A review of supporting evidence. American Journal of Psychiatry, 122, 509–522.

    Article  PubMed  Google Scholar 

  • Sennett, R. (2007). The culture of the new capitalism. New Haven: Yale University Press.

    Google Scholar 

  • Shields, J., & Grant, D. (2010). Psychologising the subject: HRM, commodification, and the objectification of labour. The Economic and Labour Relations Review, 20(2), 61–76.

    Article  Google Scholar 

  • Skultans, V. (2003). From damaged nerves to masked depression: Inevitability and hope in Latvian psychiatric narratives. Social Science and Medicine, 56(12), 2421–2431.

    Article  PubMed  Google Scholar 

  • Smith, A. (2010 [1759]). Theory of moral sentiments. London: Penguin Classics.

    Book  Google Scholar 

  • Spence, R., Roberts, A., Ariti, C., & Bardsley, M. (2014). Focus on: Antidepressant prescribing trends in the prescribing of antidepressants in primary care. Nuffield Trust Foundation.

    Google Scholar 

  • Spitzer, R. l., Williams, J., & Skodol, A. E. (1980). DSM-III: The major achievements and an overview. The American Journal of Psychiatry, 137(2), 151–164.

    Article  PubMed  Google Scholar 

  • Spurling, G. K., et al. (2010). Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: A systematic review. PLoS Medicine, 7(10), e1000352.

    Article  PubMed  PubMed Central  Google Scholar 

  • Stiglitz, J. (2013). The price of inequality. London: Penguin.

    Google Scholar 

  • Stiglitz, J. (2016). The capitalist economy as a credit economy. In S. J. (Ed.), Towards a general theory of deep downturns: Presidential address from the 17th World congress of the international economic association. London: Palgrave Macmillan.

    Google Scholar 

  • Summerfield, D. (2008). How scientifically valid is the knowledge base of global mental health? British Medical Journal, 336, 992–994.

    Article  PubMed  PubMed Central  Google Scholar 

  • Tett, G. (2010). Fool’s gold. London: Abacus.

    Google Scholar 

  • Thatcher, M. (1981, May 3) Interview. Sunday Times. Retrieved from http://www.margaretthatcher.org/document/104475

  • Thorsen, D. E. (2010). The neoliberal challenge: What is neoliberalism? Contemporary Readings in Law and Social Justice, 2(2), 15–41.

    Google Scholar 

  • Tienken, C. H. (2013). Neoliberalism, social darwinism, and consumerism masquerading as school reform. Interchange, 43(4), 295–316.

    Article  Google Scholar 

  • Timimi, S. (2013). No more psychiatric labels: Campaign to abolish psychiatric diagnostic systems such as ICD and DSM (CAPSID). Self and Society, 40(4), 6–14.

    Google Scholar 

  • Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008). Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine, 358(3), 252–260.

    Article  PubMed  Google Scholar 

  • Verhaeghe, P. (2012). What about me: The struggle for identity in a market-based society. London: Scribe.

    Google Scholar 

  • Weich, S., & Lewis, G. (1998). Poverty, unemployment, and common mental disorders: Population based cohort study. British Medical Journal, 317, 115.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wesson, G., & Gould, M. (2010). Can a ‘return-to-work’ agenda fit within the theory and practice of CBT for depression and anxiety disorders? The Cognitive Behaviour Therapist, 3, 27–42. doi:10.1017/S1754470X10000036.

    Article  Google Scholar 

  • Whitaker, R. (2011). Anatomy of an epidemic: Magic bullets, psychiatric drugs, and the astonishing rise of mental illness in America. New York: Broadway Books.

    Google Scholar 

  • Whitaker, R., & Cosgrove, L. (2015). Psychiatry under the influence: Institutional corruption, social injury, and prescriptions for reform. New York, NY: Palgrave Macmillan.

    Book  Google Scholar 

  • Whitney, P., & Ochsman, R. B. (1989). Psychology and productivity. London: Springer.

    Google Scholar 

  • Williams, S. J., Martin, P., & Gabe, J. (2010). The pharmaceuticalisation of society? A framework for analysis. Sociology of Health and Illness, 33(5), 710–725.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 The Author(s)

About this chapter

Cite this chapter

Davies, J. (2017). Political Pills: Psychopharmaceuticals and Neoliberalism as Mutually Supporting. In: Davies, J. (eds) The Sedated Society. Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-319-44911-1_8

Download citation

Publish with us

Policies and ethics